From the Food and Drug Administration.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Subject Terms:
    • Subject Terms:
    • Abstract:
      Presents news briefs related to actions of the U.S. Food and Drug Administration on various pharmaceutical products. Approval of a surfactant product for neonatal respiratory distress syndrome therapy; Order to stop the distribution of Cal-Ban 3000 diet tablets and capsules.